Causes of cervical cancer in the Philippines: A case-control study

Journal of the National Cancer Institute

Volumn 90, Issue 1, 1998, Pages 43-49

  Ngelangel, Cora ^a   Muñoz, Nubia ^b   Bosch, F Xavier ^c   Limson, Genara M ^a   Festin, Mario R ^a   Deacon, Judith ^d   Jacobs, Marcel V ^e   Santamaria, Mercedes ^f   Meijer, Chris J L M ^e   Walboomers, Jan M M ^e  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Universidad Pública de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PHILIPPINES; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS TYPING; WART VIRUS;

EID: 2642676019     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.1.43     Document Type: Article

References (26)

1. Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-9.
2. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-9.
3. Bosch FX, Munoz N, de Sanjose S, Navarro C, Moreo P, Ascunce N, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-22.
4. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85: 958-64.
5. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, et al. Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65:601-6.
6. IARC. Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol 64. Human papillomaviruses. Lyon: International Agency for Research on Cancer, 1995.
7. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76: 1057-62.
8. Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high-and low-risk human papillomavirus genotypes by general primer-mediated PCR reaction and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33: 901-5.
9. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, editors. Cancer incidence in five continents, vol VI (IARC Sci Publ No. 120), Lyon: International Agency for Research on Cancer, 1992.
10. van Nagell JR Jr, Higgins RV. Clinical invasive carcinoma of cervix: clinical features, diagnosis, staging and pretreatment evaluation. In: Coppleson M, Monaghan JM, Morrow CP, Tattersall MH, editors. Gynecologic oncology, vol 1. 2nd ed. Edinburgh: Churchill-Livingstone, 1992:663-71.
11. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Ehrlich HA, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
12. Walboomers JM, Melkert PW, van den Brule AJ, Snijders PJ, Meijer CJ. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. In: Herrington CS, McGee O, editors. Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press, 1992:152-72.
13. de Roda Husman AM, Walboomers JM, Meijer CJ, Risse EK, Schipper ME, Helmerhorst TJ, et al. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 1994;56:802-6.
14. Myers G, Delius J, Icenogle J, Bernard HU, Favre M, van Ranst M, et al, editors. Human papillomavirus compendium: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos (NM): Los Alamos National Laboratory, 1995.
15. Myers G, Halpern A, Baker C, McBride A, Wheeler C, Doorbar J, editors. Human papillomavirus compendium: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos (NM): Los Alamos National Laboratory, 1996.
16. Higgins DG, Sharp PH. CLUSTAL: a package for performing sequence alignment on a microcomputer. Gene 1988;73:237-44.
17. Walboomers JM, Melchers WJ, Mullink H, Meijer CJ, Struyk A, Quint WG, et al. Sensitivity of in situ detection with biotinylated probes of human papilloma virus type 16 DNA in frozen tissue sections of squamous cell carcinomas of the cervix. Am J Pathol 1988;131: 587-94.
18. Breslow NE, Day NE, editors. Statistical methods in cancer research. Vol. 1: The analysis of case-control studies (IARC Sci Publ No. 32). Lyon: International Agency for Research on Cancer, 1980.
19. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
20. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
21. Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992;52:750-8.
22. Chaouki N, Bosch FX, Munoz N, Meijer CJ, El Gueddari B, El Ghazi A, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer. In press.
23. Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-7.
24. Schiffman MH, Schatzkin A. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res 1994;54(7 Suppl):1944s-1947s.
25. Bosch FX, de Sanjose S, Munoz N. Correspondence Re: M. H. Schiffman and A. Schatzkin, Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res 1994;54(7 Suppl): 1944s-1947s [letter]. Cancer Res 1994;54: 6288-9.
26. Bosch FX, de Sanjose S, Munoz N. Correspondence Re: M. H. Schiffman and A. Schatzkin, Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res 1994;54(7 Suppl): 1944s-1947s [letter]. Cancer Res 1994;54: 6288-9.